MCM2 and breast carcinoma: In our current study, we evaluated nuclear protein markers either expressed throughout (Ki67, MCM2), from post G1 (Cyclin A) or in M-phase (PHH3) of the cell cycle and their connections with the routinely used predictive and prognostic factors in breast cancer.